Less expression of cyclin E in cutaneous squamous cell carcinomas than in benign and premalignant keratinocytic lesions

Journal of Cutaneous Pathology

Volumn 24, Issue 5, 1997, Pages 305-308

  Bito, Toshinori ^a   Ueda, Masato ^a   Ito, Akiro ^a   Ichihashi, Masamitsu ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN E;

ACTINIC KERATOSIS; ANTIGEN EXPRESSION; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; BREAST CANCER; CARCINOGENESIS; CONTROLLED STUDY; EPIDERMIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; KERATOACANTHOMA; KERATOSIS; MAJOR CLINICAL STUDY; PROGNOSIS; SEBORRHEIC KERATOSIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CYCLINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; KERATOSIS; PRECANCEROUS CONDITIONS; SKIN NEOPLASMS;

EID: 0030954435     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1997.tb00796.x     Document Type: Article

References (11)

1. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994: 54: 4855.
2. Kamp A, Grius NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994: 264: 436.
3. Hunter T, Pines J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 1994: 79: 573.
4. Sherr CJ. G1 phase progression: cycling on cue. Cell 1994: 79: 551.
5. Bito T, Ueda M, Ahmed NU, Nagano T, Ichihashi M. Cyclin D and retinoblastoma gene product expression in actinic keratosis and cutaneous squamous cell carcinoma in relation to p53 expression. J Cutan Pathol 1995: 22: 427.
6. Keyomarsi K, Pardee AB. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 1993: 90: 1112.
7. Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB. Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 1994: 54: 380.
8. Keyomarsi K, Conte Jr D, Toyofuku W, Fox MP. Deregulation of cyclin E in breast cancer. Oncogene 1995: 11: 941.
9. Dutta A, Chandra R, Leiter LM, Lester S. Cyclins as markers of tumor proliferation: immunohistochemical studies in breast cancer. Proc Natl Acad Sci USA 1995: 92: 5386.
10. Don Q-P, Pardee AB, Keyomarsi K. Cyclin E - a better prognostic marker for breast cancer than cyclin D? Nature Medicine 1996: 2: 254.
11. Kip1. Cancer Res 1996: 56: 1389.